Yong Dong

724 total citations · 1 hit paper
22 papers, 599 citations indexed

About

Yong Dong is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yong Dong has authored 22 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 8 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Yong Dong's work include Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (6 papers) and Cancer-related molecular mechanisms research (5 papers). Yong Dong is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (6 papers) and Cancer-related molecular mechanisms research (5 papers). Yong Dong collaborates with scholars based in China and United States. Yong Dong's co-authors include Wen‐Wen Zhang, Jiayuan Sun, Zhen‐Yu He, Jun Wang, San‐Gang Wu, Yongxiong Chen, San‐Gang Wu, Wenyan Du, Alfred E. Chang and Jinye Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Materials Chemistry A and Archives of Biochemistry and Biophysics.

In The Last Decade

Yong Dong

21 papers receiving 595 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery

2019 314 citations San‐Gang Wu, Wen‐Wen Zhang et al. Frontiers in Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yong Dong China	11	228	222	171	98	72	22	599
Xianfu Sun China	13	279 1.2×	262 1.2×	219 1.3×	44 0.4×	62 0.9×	42	586
Stephanie M. Cohen United States	17	350 1.5×	206 0.9×	252 1.5×	120 1.2×	82 1.1×	35	813
Xiao Sun China	16	398 1.7×	240 1.1×	145 0.8×	94 1.0×	79 1.1×	40	795
Gemma Shay United States	9	299 1.3×	242 1.1×	320 1.9×	105 1.1×	72 1.0×	10	637
Xianglin Yuan China	13	283 1.2×	195 0.9×	271 1.6×	118 1.2×	120 1.7×	32	691
Daniel J. Smit Germany	13	286 1.3×	179 0.8×	283 1.7×	85 0.9×	72 1.0×	41	609
Christine Mehner United States	14	423 1.9×	284 1.3×	339 2.0×	96 1.0×	77 1.1×	23	849
Sifan Zhang China	7	289 1.3×	208 0.9×	191 1.1×	119 1.2×	103 1.4×	19	664
Zhenzhen Xu China	13	268 1.2×	181 0.8×	215 1.3×	61 0.6×	72 1.0×	28	575
Marc Guiu Spain	14	454 2.0×	228 1.0×	353 2.1×	119 1.2×	107 1.5×	20	848

Countries citing papers authored by Yong Dong

Since Specialization

Citations

This map shows the geographic impact of Yong Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Dong more than expected).

Fields of papers citing papers by Yong Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Dong. The network helps show where Yong Dong may publish in the future.

Co-authorship network of co-authors of Yong Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Dong. A scholar is included among the top collaborators of Yong Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Dong. Yong Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dong, Yong, et al.. (2025). Liquid metal/elastomer composites with strain invariant electromagnetic shielding. Composites Communications. 56. 102364–102364. 1 indexed citations

Dong, Yong, et al.. (2025). Modified silicone rubber with super-stretch and high-temperature resistance for liquid metal/elastomer composites with electrical insulation and strain-invariant electromagnetic shielding. Journal of Material Science and Technology. 230. 186–194. 4 indexed citations

Du, Yiming, Xiaofei Li, Jincheng Liu, et al.. (2023). Ethanol-assisted room-temperature rapid self-healing polydimethylsiloxane-polyurea/carbon composite elastomers for energy harvesters and smart sensors. Journal of Materials Chemistry A. 12(4). 2024–2035. 22 indexed citations

Tian, Tian, Yong Dong, Ye Zhu, et al.. (2021). Hypoxia-induced CNPY2 upregulation promotes glycolysis in cervical cancer through activation of AKT pathway. Biochemical and Biophysical Research Communications. 551. 63–70. 13 indexed citations

Wu, San‐Gang, Jian Lei, Hua Li, et al.. (2021). circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade. Cancer Cell International. 21(1). 277–277. 18 indexed citations

Du, Wenyan, et al.. (2021). MicroRNA-149 is downregulated in Alzheimer’s disease and inhibits β-amyloid accumulation and ameliorates neuronal viability through targeting BACE1. Genetics and Molecular Biology. 44(1). e20200064–e20200064. 22 indexed citations

Dong, Yong, et al.. (2020). LINC00619 restricts gastric cancer progression by preventing microRNA-224-5p-mediated inhibition of OPCML. Archives of Biochemistry and Biophysics. 689. 108390–108390. 9 indexed citations

Yan, Chunxiao, Liping Wu, Hangyu Wang, et al.. (2020). LncRNA HULC shRNA disinhibits miR-377-5p to suppress the growth and invasion of hepatocellular carcinoma in vitro and hepatocarcinogenesis in vivo. Annals of Translational Medicine. 8(20). 1294–1294. 18 indexed citations

Zhang, Wen‐Wen, Qin Tong, Jiayuan Sun, et al.. (2019). 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer. Frontiers in Oncology. 9. 270–270. 8 indexed citations

10.

Wang, Jun, Jiapeng Deng, Jiayuan Sun, et al.. (2019). Noninferior Outcome After Breast-Conserving Treatment Compared to Mastectomy in Breast Cancer Patients With Four or More Positive Lymph Nodes. Frontiers in Oncology. 9. 143–143. 10 indexed citations

11.

Wu, San‐Gang, Wen‐Wen Zhang, Jun Wang, et al.. (2019). 21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery. Frontiers in Oncology. 9. 1–1. 314 indexed citations breakdown →

12.

Wu, San‐Gang, Wen‐Wen Zhang, Jun Wang, et al.. (2019). <p>Effect of 21-gene recurrence score in decision-making for surgery in early stage breast cancer</p>. OncoTargets and Therapy. Volume 12. 2071–2078. 1 indexed citations

13.

Dong, Yong, Wen‐Wen Zhang, Jun Wang, et al.. (2019). The 21-Gene Recurrence Score and Effects of Adjuvant Radiotherapy After Breast Conserving Surgery in Early-Stage Breast Cancer. Future Oncology. 15(14). 1629–1639. 7 indexed citations

14.

Zhang, Wen‐Wen, et al.. (2018). The effects of postoperative radiotherapy on survival outcomes in patients under 65 with estrogen receptor positive tubular breast carcinoma. Radiation Oncology. 13(1). 226–226. 6 indexed citations

15.

Zhang, Wen‐Wen, San‐Gang Wu, Yihong Ling, et al.. (2018). Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study. Cancer Management and Research. Volume 10. 4509–4515. 9 indexed citations

16.

Wu, San‐Gang, Wen‐Wen Zhang, Jun Wang, et al.. (2018). Inflammatory Breast Cancer Outcomes by Breast Cancer Subtype: A Population-Based Study. Future Oncology. 15(5). 507–516. 19 indexed citations

17.

Wang, Jun, Zhen‐Yu He, Yong Dong, et al.. (2018). The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic Subtypes. Frontiers in Genetics. 9. 20 indexed citations

18.

Fang, Yong, Xiaoyun Zhou, Lili Liu, et al.. (2017). Relationship of metformin with the risk of pancreatic cancer in patients with type 2 diabetes: a meta-analysis. Biomedical Research-tokyo. 28(10). 4439–4444. 3 indexed citations

19.

Xu, Zumin, Yufang Zuo, Jin Wang, et al.. (2015). Overexpression of the regulator of G-protein signaling 5 reduces the survival rate and enhances the radiation response of human lung cancer cells. Oncology Reports. 33(6). 2899–2907. 15 indexed citations

20.

Lin, Guo‐He, Jin Wang, Xiang‐Ming Lao, et al.. (2012). Interleukin-6 Inhibits Regulatory T Cells and Improves the Proliferation and Cytotoxic Activity of Cytokine-induced Killer Cells. Journal of Immunotherapy. 35(4). 337–343. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact